Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
OPtimizing CNS drug development using molecular imaging.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy.
MRI unsampling using feature-based non-local means approach.
Update on multiple sclerosis treatments.
Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
[Optic Neuritis.]
Comparing two conditions of administering the six-minute walk test in people with multiple sclerosis.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study.
Sphingolipids in neuroinflammation.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
Is metabolic flexibility altered in multiple sclerosis patients?
Chromatin Landscape Defined by Repressive Histone Methylation during Oligodendrocyte Differentiation.
Effects of yoga interventions on fatigue: a meta-analysis.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
[Special cases of multiple sclerosis].
To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
Pages
« first
‹ previous
…
260
261
262
263
264
265
266
267
268
…
next ›
last »